undamentalytics Newsletter
Sign in

Rockwell Medical, Inc. income statement

In fiscal 2025, Rockwell Medical, Inc. reported revenue of $69.3m, down 31.8% on the year before, operating income of −$4.7m (a -6.8% margin) and net income of −$5.3m, or −$0.15 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue5560495052545553576361626273841016969
Cost of revenue————————54655859646975845857
Gross profit8106779974−233−249171212
Research and development63184839856667773100—
Selling, general and administrative791013141819212323————————
Selling and marketing——————————98622322
General and administrative——————————2116151612141415
Operating income−5−3−22−54−47−18−15−20−26−32−35−28−30−17−71−5−5
Interest expense——————————02222111
Net interest income−0−0−0−0−2−4——110———————
Income before tax−6−3−21−54−49−21−14−19−26—————−8−0−5—
Income tax—0000000000000000—
Net income−6−3−21−54−49−21−14−20−26−32−34−31−33−19−8−0−5−5
Diluted EPS−$0.37−$1.76−$13.31−$2.65−$1.48−$0.52−$0.29−$0.39−$5.61−$0.61−$6.16−$0.41−$3.83−$1.31−$0.37−$0.03−$0.15—
Diluted shares (average)—2m2m2m3m4m5m5m5m5m6m7m9m14m23m31m36m—
EBITDA−4−1−21−53−46−17−14−19−25−32−34−28−30−16−53−2−3

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DERM vs RMTIAYTU vs RMTIAQST vs RMTI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Rockwell Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rockwell Medical, Inc.